IM8 Welcomes Giannis Antetokounmpo As Minority Equity Investor With $100 Million ARR
IM8, a rapidly growing supplement brand founded in late 2024 by Prenetics (NASDAQ: PRE) and David Beckham, has welcomed legendary NBA star Giannis Antetokounmpo as a minority equity investor. The company, known for it…
IM8, a rapidly growing supplement brand founded in late 2024 by Prenetics (NASDAQ: PRE) and David Beckham, has welcomed legendary NBA star Giannis Antetokounmpo as a minority equity investor. The company, known for its clinically-dosed longevity products backed by a world-class Scientific Advisory Board, reached $100 million in ARR within 11 months and anticipates over $180 million in revenue in 2026, joining other athlete investors including Aryna Sabalenka, Ollie Bearman, and Beckham.
HQ: Charlotte, North Carolina
#VentureCapital #IM8 #GiannisAntetokounmpo #DavidBeckham #TradedVC
ABOUT THE DEAL
- Raise
- $100M
- Round
- Not stated
- Company
- IM8 Welcomes Giannis Antetokounmpo As Minority Equity Investor With $100 Million ARR
- Desk
- Deals
- Filed
- Apr 3, 2026
